tiprankstipranks
Immunome price target lowered to $25 from $35 at Guggenheim
PremiumThe FlyImmunome price target lowered to $25 from $35 at Guggenheim
7d ago
Immunome reports FY24 revenue $9.04M, consensus $9.41M
Premium
The Fly
Immunome reports FY24 revenue $9.04M, consensus $9.41M
8d ago
Immunome initiated with an Outperform at LifeSci Capital
Premium
The Fly
Immunome initiated with an Outperform at LifeSci Capital
16d ago
Immunome CFO Relocation and Compensation Package Unveiled
PremiumCompany AnnouncementsImmunome CFO Relocation and Compensation Package Unveiled
2M ago
Hummingbird Bioscience licenses antibodies to Immunome
Premium
The Fly
Hummingbird Bioscience licenses antibodies to Immunome
3M ago
Immunome files to sell 1.8M shares of common stock for holders
Premium
The Fly
Immunome files to sell 1.8M shares of common stock for holders
4M ago
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe FlyMolson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
5M ago
Immunome initiated with an Overweight at Stephens
Premium
The Fly
Immunome initiated with an Overweight at Stephens
5M ago
Immunome initiated with an Overweight at Stephens on ‘seasoned leadership’
Premium
The Fly
Immunome initiated with an Overweight at Stephens on ‘seasoned leadership’
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100